Top-Rated StocksTop-RatedPositive News SentimentPositive NewsNYSE:EHC Encompass Health (EHC) Stock Price, News & Analysis $100.75 -0.39 (-0.39%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$100.33 -0.42 (-0.42%) As of 03/28/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Encompass Health Stock (NYSE:EHC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Encompass Health alerts:Sign Up Key Stats Today's Range$100.06▼$101.8050-Day Range$93.57▼$102.3152-Week Range$78.53▼$104.55Volume457,600 shsAverage Volume649,885 shsMarket Capitalization$10.15 billionP/E Ratio22.59Dividend Yield0.67%Price Target$107.67Consensus RatingBuy Company OverviewEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.Read More… Remove Ads Encompass Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreEHC MarketRank™: Encompass Health scored higher than 87% of companies evaluated by MarketBeat, and ranked 108th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.6 / 5Analyst RatingBuy Consensus RatingEncompass Health has received a consensus rating of Buy. The company's average rating score is 3.18, and is based on 9 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEncompass Health has only been the subject of 4 research reports in the past 90 days.Read more about Encompass Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth10.00% Earnings GrowthEarnings for Encompass Health are expected to grow by 10.00% in the coming year, from $4.80 to $5.28 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Encompass Health is 22.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.Price to Earnings Ratio vs. SectorThe P/E ratio of Encompass Health is 22.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.33.Price to Earnings Growth RatioEncompass Health has a PEG Ratio of 2.31. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioEncompass Health has a P/B Ratio of 3.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Encompass Health's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.10% of the float of Encompass Health has been sold short.Short Interest Ratio / Days to CoverEncompass Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Encompass Health has recently decreased by 1.42%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldEncompass Health has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthEncompass Health does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Encompass Health is 15.25%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Encompass Health will have a dividend payout ratio of 12.88% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.Read more about Encompass Health's dividend. Sustainability and ESG5.0 / 5Environmental Score-0.71 Percentage of Shares Shorted2.10% of the float of Encompass Health has been sold short.Short Interest Ratio / Days to CoverEncompass Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Encompass Health has recently decreased by 1.42%, indicating that investor sentiment is improving. News and Social Media3.2 / 5News Sentiment1.68 News SentimentEncompass Health has a news sentiment score of 1.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 14 news articles for Encompass Health this week, compared to 7 articles on an average week.Search InterestOnly 5 people have searched for EHC on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Encompass Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Encompass Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $495,578.00 in company stock.Percentage Held by InsidersOnly 2.10% of the stock of Encompass Health is held by insiders.Percentage Held by Institutions97.25% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Encompass Health's insider trading history. Receive EHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EHC Stock News HeadlinesRehabilitation Hospital of Athens Now Open in GeorgiaMarch 18, 2025 | prnewswire.comEncompass Health at Barclays Conference: Strategic Growth and ChallengesMarch 13, 2025 | uk.investing.comMusk’s real agenda in D.C. In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…March 29, 2025 | Porter & Company (Ad)Encompass Health to Participate in Barclays Global Healthcare ConferenceFebruary 26, 2025 | prnewswire.comEncompass Health Declares Dividend on Common StockFebruary 20, 2025 | prnewswire.comEncompass Health's SWOT analysis: stock poised for growth amid healthcare demandFebruary 17, 2025 | msn.comAndrew Price Executes Sell Order: Offloads $495K In Encompass Health StockFebruary 14, 2025 | benzinga.comEncompass Health (EHC) Gets a Buy from Truist FinancialFebruary 14, 2025 | markets.businessinsider.comSee More Headlines EHC Stock Analysis - Frequently Asked Questions How have EHC shares performed this year? Encompass Health's stock was trading at $92.35 at the beginning of 2025. Since then, EHC stock has increased by 9.1% and is now trading at $100.7490. View the best growth stocks for 2025 here. How were Encompass Health's earnings last quarter? Encompass Health Co. (NYSE:EHC) issued its earnings results on Thursday, February, 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a trailing twelve-month return on equity of 17.56% and a net margin of 8.48%. Is Encompass Health buying back stock? Encompass Health's board initiated a stock buyback program on Wednesday, July 24th 2024, which allows the company to buy back $500,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 5.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued. Does Encompass Health have any subsidiaries? Encompass Health subsidiaries include Baptist Outpatient Services Inc., Frontier Home Health and Hospice, Generation Solutions of Lynchburg LLC, Alacare Home Health & Hospice, Camellia Healthcare, CareSouth Health System Inc., Reliant Hospital Partners LLC, and others. Who are Encompass Health's major shareholders? Top institutional shareholders of Encompass Health include Vanguard Group Inc. (10.33%), Invesco Ltd. (5.50%), Wellington Management Group LLP (4.00%) and Alliancebernstein L.P. (2.06%). Insiders that own company stock include Mark J Tarr, Douglas E Coltharp, John Patrick Darby, Andrew L Price, Elissa Joy Charbonneau, Greg D Carmichael and Kevin J O'connor. View institutional ownership trends. How do I buy shares of Encompass Health? Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Encompass Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Encompass Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET). Company Calendar Record date for 1/15 Dividend1/02/2025Ex-Dividend for 1/15 Dividend1/02/2025Dividend Payable1/15/2025Last Earnings2/06/2025Today3/29/2025Record date for 4/15 Dividend4/01/2025Ex-Dividend for 4/15 Dividend4/01/2025Dividend Payable4/15/2025Next Earnings (Estimated)4/23/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospitals Sub-IndustryHealth Care Facilities Current SymbolNYSE:EHC CIK785161 Webwww.healthsouth.com Phone(205) 967-7116Fax205-969-4719Employees35,000Year Founded1984Price Target and Rating Average Stock Price Target$107.67 High Stock Price Target$120.00 Low Stock Price Target$95.00 Potential Upside/Downside+6.9%Consensus RatingBuy Rating Score (0-4)3.18 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$4.46 Trailing P/E Ratio22.59 Forward P/E Ratio20.99 P/E Growth2.31Net Income$455.70 million Net Margins8.48% Pretax Margin13.95% Return on Equity17.56% Return on Assets7.06% Debt Debt-to-Equity Ratio0.84 Current Ratio1.05 Quick Ratio1.04 Sales & Book Value Annual Sales$5.37 billion Price / Sales1.89 Cash Flow$7.63 per share Price / Cash Flow13.21 Book Value$27.72 per share Price / Book3.63Miscellaneous Outstanding Shares100,709,000Free Float98,634,000Market Cap$10.15 billion OptionableOptionable Beta0.92 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSE:EHC) was last updated on 3/29/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Encompass Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Encompass Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.